Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Cash from Investing Activities (2022 - 2025)

Historic Cash from Investing Activities for HeartSciences (HSCS) over the last 4 years, with Q4 2025 value amounting to -$15770.0.

  • HeartSciences' Cash from Investing Activities fell 16994.18% to -$15770.0 in Q4 2025 from the same period last year, while for Oct 2025 it was -$40097.0, marking a year-over-year increase of 6794.39%. This contributed to the annual value of -$30188.0 for FY2025, which is 7590.18% up from last year.
  • According to the latest figures from Q4 2025, HeartSciences' Cash from Investing Activities is -$15770.0, which was down 16994.18% from -$814.0 recorded in Q3 2025.
  • Over the past 5 years, HeartSciences' Cash from Investing Activities peaked at -$814.0 during Q3 2025, and registered a low of -$69228.0 during Q2 2024.
  • For the 4-year period, HeartSciences' Cash from Investing Activities averaged around -$14642.4, with its median value being -$7247.0 (2022).
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first tumbled by 131772.85% in 2024, then surged by 8871.55% in 2025.
  • Quarter analysis of 4 years shows HeartSciences' Cash from Investing Activities stood at -$7247.0 in 2022, then skyrocketed by 73.06% to -$1952.0 in 2023, then crashed by 199.28% to -$5842.0 in 2024, then plummeted by 169.94% to -$15770.0 in 2025.
  • Its last three reported values are -$15770.0 in Q4 2025, -$814.0 for Q3 2025, and -$7812.0 during Q2 2025.